Recruiting for Acute Myocardial Infarction Cell Therapy Trials: Challenges and Best Practices for the CCTRN.
Rachel E Olson, Rachel W Vojvodic, Judy Bettencourt, Eileen M Handberg, Elizabeth Szymanski, Deirdre Smith, Jody LaRock, Shreela V Sharma, Doris A Taylor, Timothy D Henry
Article in Clinical researcher (Alexandria, Va.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Rachel E OlsonMinneapolis Heart Institute Foundation. She can be reached at rachel.olson@allina.com.
Rachel W VojvodicUniversity of Texas School of Public Health-Houston, and a project manager with the Cardiovascular Cell Therapy Research Network (CCTRN). She can be reached at rachel.w.vojvodic@uth.tmc.edu.
Judy BettencourtUniversity of Texas School of Public Health-Houston, and one of three project managers for the Data Coordinating Center supporting the CCTRN. She can be contacted at Judith.l.bettencourt@uth.tmc.edu.
Eileen M HandbergCardiovascular Clinical Trials Program in the Division of Cardiovascular Medicine at the University of Florida, as well as an associate professor of medicine, institutional review board member, and Cardiovascular Division representative on the College of Medicine Continuing Medical Education Committee. She is also program director for the practitioner competency assessment program called Florida CARES. She can be reached at Eileen.Handberg@medicine.ufl.edu.
Elizabeth SzymanskiFlorida Hospital Tampa, Pepin Heart Institute. She can be reached at elizabeth.szymanski@ahss.org.
Deirdre SmithStem Cell Center at Texas Heart Institute, as well as the president of the ACRP Greater Houston Chapter. She can be reached at dxsmith@texasheart.org.
Jody LaRockSpecial and Intensive Cardiac Care units of United Hospital, part of Allina Health. She can be reached at jody.larock@allina.com.
Shreela V SharmaDivision of Epidemiology at the University of Texas, School of Public Health. She can be reached at Shreela.V.Sharma@uth.tmc.edu.
Doris A TaylorRegenerative Medicine Research at the Texas Heart Institute. She co-directs the CCTRN Biorepository and leads a cell and cytokine profiling core lab that serves multiple NHLBI networks, medical centers, and research foundations in the U.S. and Canada. She can be contacted at dtaylor@texasheart.org.
Timothy D HenryCedars-Sinai Heart Institute in Los Angeles, Calif. He can br reached at henryt@cshs.org.
Funding
Data Coordinating Center For The Cardiovascular Cell Therapy Research NetworkUM1HL087318 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI DAVIS, BARRY R · 2012 to 2018
$29.8M
Cardiovascular Cell Therapy Research Network - Data Coordinating CenterU01HL087318 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MOYE, LEMUEL A. · 2007 to 2011
$17.6M
MN Regional Cardiovascular Cell Therapy Clinical Res. Network: From AMI to PADUM1HL087394 · NHLBI · UNIVERSITY OF MINNESOTA · PI HENRY, TIMOTHY D · 2012 to 2018
$5.1M
UFRCC for Cardiovascular Cell Therapy Research NetworkUM1HL087366 · NHLBI · UNIVERSITY OF FLORIDA · PI PEPINE, CARL J · 2012 to 2018
$4.7M
UFCC for Cardiovascular Cell Therapy Research NetworkU01HL087366 · NHLBI · UNIVERSITY OF FLORIDA · PI PEPINE, CARL J · 2007 to 2011
$2.6M
MN Cardiovascular Cell Therapy Clinical Research Network: From AMI to CHFU01HL087394 · NHLBI · UNIVERSITY OF MINNESOTA · PI HENRY, TIMOTHY D · 2007 to 2011
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Recruiting for Acute Myocardial Infarction Cell Therapy Trials: Challenges and Best Practices for the CCTRN. · full record | OpenQuestion